LEONARDO S.P.A. EO 4,40/ IT0003856405 /
2024-04-29 8:06:19 AM | Chg. +0.500 | Volume | Bid4:25:37 PM | Ask4:25:37 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
21.960EUR | +2.33% | 0 Turnover: 0.000 |
21.940Bid Size: 1,002 | 21.970Ask Size: 1,000 | 12.58 bill.EUR | 1.28% | 19.12 |
GlobeNewswire
1:00 PM
Lithium Ionic Reports Exceptional Drill Results from Bandeira of 1.25% Li2O over 50m, 1.46% Li2O ove...
GlobeNewswire
04-23
Lithium Ionic Expands Newly Discovered Zone at Salinas; Drills 1.53% Li2O over 15m, incl. 2.31% Li2O...
GlobeNewswire
04-23
CDR-Life to Present Tumor Targeting Capabilities of M-gager® Platform at the TCR-Based Therapies for...
GlobeNewswire
04-17
Final Day of Questex’s IHIF EMEA 2024 offers a positive outlook for the future of hospitality invest...
GlobeNewswire
04-17
Talisker Intersects 56.88 g/t Au over 1.00 Metre from the Bralorne Gold Project Resource Conversion ...
GlobeNewswire
04-12
Lithium Ionic Announces 26% Increase in Global Mineral Resources with an Updated Mineral Resource Es...
GlobeNewswire
04-11
Luminosity Partners with Kroger to Launch the Luminosity Invitational Presented by Kroger Gaming
GlobeNewswire
04-04
Lithium Ionic Announces Maiden Mineral Resource Estimate and Initiation of PEA at its Salinas Projec...
GlobeNewswire
04-02
Talisker Intersects 38.17 g/t Au over 5.20 Metres from the Bralorne Gold Project Resource Conversion...
GlobeNewswire
03-27
When Art Meets AI: A Revolutionary Dialogue with Digital Human Mona Lisa on Female Empowerment
GlobeNewswire
03-27
FTI Consulting Adds Former Mexican Government Energy Official to Growing Litigation & Disputes Resol...
GlobeNewswire
03-21
Eledon Pharmaceuticals Announces Use of Tegoprubart in First-ever Transplant of Genetically Modified...
GlobeNewswire
03-19
Pluxee reinforces Leadership Team to accelerate the execution of its strategic growth
GlobeNewswire
03-01
Talisker Intersects 24.41 g/t Au over 1.50 metres from the Bralorne Gold Project Resource Conversio...
GlobeNewswire
02-28
Kiromic BioPharma to Present at the OTC Markets’ Virtual Life Science Investor Forum on March 7th